News & Articles

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications

First-to-market reagents enable native gene overexpression for meaningful gain-of-function studies

Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples

TATAA Biocenter also to introduce Swift Biosciences’ NGS products in its popular NGS training courses